Company to view next
Generic selectors
Exact matches only
Search in title
Search in content

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal diseases, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

167

Address:

Adverum Biotechnologies, Inc. 800 Saginaw Drive Redwood City CA 94063 United States

Website:

Home

Phone:

650-656-9323

Leave a comment

Your email address will not be published. Required fields are marked *